March/April 2011, Vol 4, No 2

Regulatory, Perspectives
Comparative Effectiveness Research in the United States: A Catalyst for Innovation
Riaz Ali, MPP, Morgan Hanger, MPP, Tanisha Carino, PhD
Read More
Clinical, Drug Updates
Strategies to Prevent Opioid Misuse, Abuse, and Diversion That May Also Reduce the Associated Costs
Kathryn L. Hahn, PharmD, DAAPM, CPE
Stakeholder Perspective
Just Say No
by Atheer A. Kaddis, PharmD
Read More
Industry Trends
New Economic Analysis Zeroes in on Low Generic Utilization and Waste in Medicaid
Dalia Buffery, MA, ABD
Read More
Industry Trends
CMS Invites Feedback on the Proposed Accountable Care Organizations Rules
Dalia Buffery, MA, ABD
Read More
Industry Trends
The Patient-Centered Medical Home: An Essential Destination on the Road to Reform
Matt Adamson
Read More
Business, Original Research
Recent Trends in the Dispensing of 90-Day-Supply Prescriptions at Retail Pharmacies: Implications for Improved Convenience and Access
Joshua N. Liberman, PhD, Charmaine Girdish, MPH
Stakeholder Perspective
When More Is Almost Always Better
by Walid F. Gellad, MD, MPH
Read More
Business, Original Research
Comparing Treatment Persistence, Healthcare Resource Utilization, and Costs in Adult Patients with Major Depressive Disorder Treated with Escitalopram or Citalopram
Eric Q. Wu, PhD, Paul E. Greenberg, MA, Rym Ben-Hamadi, MSc, Andrew P. Yu, PhD, Elaine H. Yang, PhD, M. Haim Erder, PhD
Stakeholder Perspective
Efficacy and Cost-Effectiveness: Escitalopram versus Citalopram
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More

Results 1 - 7 of 7
SUBSCRIBE
Copyright © Amplity Medical Communications. All rights reserved.